Who
Jorey Chernett
10% owner
Company insider
Files Form 4 as: 10% owner, Exagen; 10% owner, Starling Oncology; 10% owner, Neuronetics; 10% owner, AirSculpt Technologies.
In numbers
- Trades disclosed
- 103
- Buys
- 44
- Sells
- 0
- Bought
- $19.1M
- Sold
- $0
- Companies
- 4
- Companies where not an officer
- 4
- First trade
- 3 Mar 2026
- Last trade
- 19 Oct 2026
- Last filed
- 20 Oct 2026
Companies traded
Activity over time
1 Mar – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 19 Oct 2026filed 20 Oct 2026 | XGN ExagenDiagnostics & Labs | SEC FORM 4 Bought | $104K14,000 at $7.46 | filing |
| 14 Aug 2026filed 17 Aug 2026 | STLN Starling OncologyProviders & Facilities | SEC FORM 4 Bought | $78K12,000 at $6.54 | filing |
| 14 Aug 2026filed 17 Aug 2026 | STLN Starling OncologyProviders & Facilities | SEC FORM 4 Bought | $78K12,000 at $6.54 | filing |
| 14 Aug 2026filed 17 Aug 2026 | STIM NeuroneticsMedical Devices | SEC FORM 4 Bought | $44K14,000 at $3.16 | filing |
| 14 Aug 2026filed 17 Aug 2026 | STIM NeuroneticsMedical Devices | SEC FORM 4 Bought | $44K14,000 at $3.16 | filing |
| 13 Aug 2026filed 17 Aug 2026 | STLN Starling Oncologyoption or derivative · Providers & Facilities | SEC FORM 4 Code S | $624100 at $6.24 | filing |
| 13 Aug 2026filed 17 Aug 2026 | STLN Starling Oncologyoption or derivative · Providers & Facilities | SEC FORM 4 Code S | $624100 at $6.24 | filing |
| 13 Aug 2026filed 17 Aug 2026 | STIM Neuroneticsoption or derivative · Medical Devices | SEC FORM 4 Code S | $321100 at $3.21 | filing |
| 13 Aug 2026filed 17 Aug 2026 | STIM Neuroneticsoption or derivative · Medical Devices | SEC FORM 4 Code S | $321100 at $3.21 | filing |
| 21 Jul 2026filed 22 Jul 2026 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Bought | $95K18,000 at $5.27 | filing |
| 21 Jul 2026filed 22 Jul 2026 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Bought | $95K18,000 at $5.27 | filing |
| 14 Jul 2026filed 15 Jul 2026 | STIM NeuroneticsMedical Devices | SEC FORM 4 Bought | $62K35,000 at $1.78 | filing |
| 14 Jul 2026filed 15 Jul 2026 | STIM NeuroneticsMedical Devices | SEC FORM 4 Bought | $62K35,000 at $1.78 | filing |
| 10 Jul 2026filed 13 Jul 2026 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Bought | $88K15,000 at $5.85 | filing |
| 10 Jul 2026filed 13 Jul 2026 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Bought | $88K15,000 at $5.85 | filing |
| 23 Jun 2026filed 24 Jun 2026 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Bought | $90K18,000 at $5.02 | filing |
| 23 Jun 2026filed 24 Jun 2026 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Bought | $90K18,000 at $5.02 | filing |
| 4 Jun 2026filed 5 Jun 2026 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Bought | $57K12,000 at $4.75 | filing |
| 4 Jun 2026filed 5 Jun 2026 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Bought | $57K12,000 at $4.75 | filing |
| 20 May 2026filed 21 May 2026 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Bought | $136K33,500 at $4.07 | filing |
News
Neuronetics to Report Third Quarter 2026 Financial and Operating Results and Host Conference CallSTIM · manilatimes.net · 21 Oct 2026Canaccord Genuity Group Issues Positive Forecast for Exagen (NASDAQ:XGN) Stock PriceXGN · themarketsdaily.com · 19 Oct 2026Centene (NYSE:CNC) vs. Exagen (NASDAQ:XGN) Head to Head SurveyXGN · themarketsdaily.com · 14 Oct 2026Financial Review: Guardian Pharmacy Services (NYSE:GRDN) and AirSculpt Technologies (NASDAQ:AIRS)AIRS · dailypolitical.com · 14 Oct 2026
0 headlines in the last 90 days name Jorey Chernett; 4 articles from the last 14 days about the 4 companies they traded most, at most three about any one of them.